Unknown

Dataset Information

0

Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Sholzberg M 

PROVIDER: S-EPMC7943934 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
| S-EPMC7487448 | biostudies-literature
Unknown Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
| S-EPMC7284668 | biostudies-literature
Unknown Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry.
| S-EPMC8018202 | biostudies-literature
Unknown Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
| S-EPMC7537066 | biostudies-literature
Unknown Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial.
| S-EPMC7476433 | biostudies-literature
Unknown Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
| S-EPMC8635458 | biostudies-literature
Unknown Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.
| S-EPMC8186006 | biostudies-literature
Unknown Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
| S-EPMC8039797 | biostudies-literature
Unknown Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
| S-EPMC8797010 | biostudies-literature
Unknown Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
| S-EPMC8258474 | biostudies-literature